JP2023545501A5 - - Google Patents
Info
- Publication number
- JP2023545501A5 JP2023545501A5 JP2023522978A JP2023522978A JP2023545501A5 JP 2023545501 A5 JP2023545501 A5 JP 2023545501A5 JP 2023522978 A JP2023522978 A JP 2023522978A JP 2023522978 A JP2023522978 A JP 2023522978A JP 2023545501 A5 JP2023545501 A5 JP 2023545501A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- amino acid
- acid sequence
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063093029P | 2020-10-16 | 2020-10-16 | |
| US63/093,029 | 2020-10-16 | ||
| PCT/US2021/055216 WO2022081997A1 (en) | 2020-10-16 | 2021-10-15 | Compositions and methods for treating blood disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545501A JP2023545501A (ja) | 2023-10-30 |
| JP2023545501A5 true JP2023545501A5 (enExample) | 2024-10-22 |
Family
ID=81208704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023522978A Pending JP2023545501A (ja) | 2020-10-16 | 2021-10-15 | 血液障害を処置するための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230391858A1 (enExample) |
| EP (1) | EP4228696A4 (enExample) |
| JP (1) | JP2023545501A (enExample) |
| KR (1) | KR20230087572A (enExample) |
| AU (1) | AU2021361067A1 (enExample) |
| CA (1) | CA3195798A1 (enExample) |
| MX (1) | MX2023004429A (enExample) |
| WO (1) | WO2022081997A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201510316UA (en) | 2013-07-09 | 2016-01-28 | Annexon Inc | Anti-complement factor c1q antibodies and uses thereof |
| US12486322B2 (en) * | 2021-12-13 | 2025-12-02 | Annexon, Inc. | Anti-complement factor C1q antibodies with single binding arms and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201510316UA (en) * | 2013-07-09 | 2016-01-28 | Annexon Inc | Anti-complement factor c1q antibodies and uses thereof |
| PL3215527T3 (pl) * | 2014-11-05 | 2025-04-28 | Annexon, Inc. | Humanizowane przeciwciała przeciwko czynnikowi dopełniacza C1Q i ich zastosowanie |
| FI3380518T3 (fi) * | 2015-11-24 | 2026-05-29 | Annexon Inc | Antikomplementtitekijä-C1Q:n Fab-fragmentteja ja niiden käyttöjä |
| KR20220083737A (ko) * | 2019-10-17 | 2022-06-20 | 애넥슨, 인코포레이티드 | 혈액 장애를 치료하기 위한 조성물 및 방법 |
-
2021
- 2021-10-15 AU AU2021361067A patent/AU2021361067A1/en active Pending
- 2021-10-15 US US18/032,084 patent/US20230391858A1/en active Pending
- 2021-10-15 WO PCT/US2021/055216 patent/WO2022081997A1/en not_active Ceased
- 2021-10-15 JP JP2023522978A patent/JP2023545501A/ja active Pending
- 2021-10-15 CA CA3195798A patent/CA3195798A1/en active Pending
- 2021-10-15 EP EP21881186.7A patent/EP4228696A4/en active Pending
- 2021-10-15 KR KR1020237016264A patent/KR20230087572A/ko active Pending
- 2021-10-15 MX MX2023004429A patent/MX2023004429A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022551751A5 (enExample) | ||
| JP7042467B2 (ja) | 単鎖可変フラグメントｃｄ３結合タンパク質 | |
| JP7101621B2 (ja) | 単一ドメイン血清アルブミン結合タンパク質 | |
| JP6262715B2 (ja) | ヒト化およびキメラ抗ｃ３因子抗体、ならびにその使用 | |
| JP6244350B2 (ja) | ヒト化およびキメラ抗因子Ｂｂ抗体、ならびにその使用 | |
| US20180171030A1 (en) | Sirp-alpha agonist antibody | |
| JP2018520139A (ja) | エクリズマブまたはエクリズマブバリアントでのワクチン接種に従って患者を処置するための方法 | |
| JP2020511469A5 (enExample) | ||
| WO2012083370A1 (en) | Modified antibody with improved half-life | |
| JP2024518844A5 (enExample) | ||
| TW202214701A (zh) | 抗ＦＸＩ／ＦＸＩａ抗體、其抗原結合片段及醫藥用途 | |
| KR20200110688A (ko) | 인자 h 강화 항체 및 이의 사용 | |
| AU2020291712A1 (en) | Soluble complement receptor type 1 variant conjugates and uses thereof | |
| CN116554323B (zh) | 人源化抗il21抗体的开发和应用 | |
| JP2021178857A (ja) | Ｈ因子を強化する抗体及びその用途 | |
| CN114828886A (zh) | 因子h增强抗体及其用途 | |
| EP4228696A1 (en) | Compositions and methods for treating blood disorders | |
| JP7735545B2 (ja) | Ｃｄｃプラットホーム抗体 | |
| JP6737482B1 (ja) | 抗ポドプラニン抗体 | |
| KR20250077505A (ko) | 항-c1q 항체를 위한 제형 | |
| JP2026509811A (ja) | ヒト補体第２成分結合分子 | |
| TW202604960A (zh) | 一種治療膜性腎病變的拮抗劑及其用途 | |
| JP2024545741A (ja) | 単一特異性および二重特異性抗体ならびにその抗原結合断片 | |
| JP2023507852A5 (enExample) | ||
| TH1801007665A (th) | แอนติ-c5 แอนติบอดี และการใช้สิ่งนี้ |